Table 3.

Progress towards achieving the National Allergy Strategy goals

National Allergy Strategy	Advocacy undertaken	Outcomes to date
1.Develop standards of care to improve the health and quality of life of people with allergic diseases	The National Allergy Strategy has: •advocated for the development of an Anaphylaxis Clinical Care Standard to improve anaphylaxis recognition, treatment and management in hospitals and the community. •submitted several pre-budget submissions requesting funding for development and implementation of a shared care model for allergy which would address standards of care. •Advocating for improvements to anaphylaxis prevention and management in schools and childcare and improved anaphylaxis management legislation in childcare.	•An Acute Anaphylaxis Clinical Care Standard was developed by the Australian Commission for Safety and Quality in Health Care and released in November 2022. •The National Allergy Strategy received federal government funding to scope a national shared care model for allergic diseases in 2018–19. •The funding announced in the Federal Budget in March 2022 will enable the development of standards of care for all allergic diseases through the shared care model project. •The National Allergy Strategy received federal government funding to develop and implement best practice guidelines for the prevention and management in schools and childcare and a first step to developing minimum standards. •To date there has been no change to legislation with regards to anaphylaxis management in childcare.
2.Ensure timely access to appropriate healthcare management for people with allergic diseases	•The National Allergy Strategy advocated for funding to implement a shared care model for allergic diseases to improve timely access to appropriate healthcare providers.	•The National Allergy Strategy conducted two pilot projects to identify alternative models of care in regional areas in 2017 and 2019. •The National Allergy Strategy received federal government funding to scope a national shared care model for allergic diseases in 2018–19. •Funding was announced in the Federal Budget in March 2022 for the National Allergy Strategy to implement a national shared care model for allergic diseases.
3.Improve access to best-practice, evidence-based and consistent information, education and training on allergic diseases for health professionals, people with allergic diseases, consumers, carers and the community	The National Allergy Strategy advocated for funding for national standardisation of allergy information and education.	The National Allergy Strategy received federal government funding to: •develop nationally standardised food allergen management training for the food service industry. •develop and implement nationally standardised best practice guidelines for the prevention and management of anaphylaxis in schools and childcare. •Develop websites for different target audiences (consumers and health professionals) to provide evidence-based, best practice information. These websites provide information about allergy prevention, information specifically for teens and young adults, practical information about managing food allergies and include resource hubs directing people to other evidence-based best-practice resources develop by other credible organizations. •support the review and update of existing ASCIA anaphylaxis e-training for schools and childcare. As part of the National Allergy Strategy shared care model project funded through the Federal Budget (March 2022): •ASCIA will expand provision of evidence-based, best-practice education and training for health professionals. •Allergy & Anaphylaxis Australia will engage with consumers to identify education and resources required and appropriate formats of provision of these resources.
4.Promote patient-focused research to prevent the development of allergic diseases and improve the health and quality of life of people with allergic diseases	The National Allergy Strategy worked in collaboration with the Centre for Food & Allergy Research and advocated for a national allergy centre of excellence.	•Funding was announced in the Federal Budget in March 2022 for the Centre for Food & Allergy Research to establish a National Allergy Centre of Excellence. The National Allergy Strategy will work collaboratively with this organization to ensure effective resource development and evaluation.
5.Recognition of allergic diseases as a prioritised chronic disease and National Health Priority Area	The National Allergy Strategy initially advocated for the allergic diseases to be considered a National Health Priority Area. However, in recent years, advocacy has been focused on obtaining funding to progress project work.	•To date, allergic diseases are not recognized as a prioritised chronic disease or National Health Priority Area. However, federal government funding has facilitated increased awareness about allergic diseases in the Australian community more broadly.